Drug profile · INN
metformin
APO-METFORMIN XR 1000
metformin (APO-METFORMIN XR 1000) is a mitochondrial complex i (nadh dehydrogenase) inhibitor. Associated with Alphapharm Pty Ltd.
Drug details — metformin
- Class
- —
- Route
- —
- Patents
- 4
- Programs
- 68
- Data quality
- 0.81
Quick answer
metformin (APO-METFORMIN XR 1000) is a mitochondrial complex i (nadh dehydrogenase) inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
Mechanism of action
Mitochondrial complex I (NADH dehydrogenase) inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Related patents
-
US 10363244
Compositions comprising metformin and a glucokinase activator
granted -
US 10064846
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
granted -
US 9855251
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
granted -
US 9359313
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
granted
Frequently asked questions
What is metformin?
metformin (APO-METFORMIN XR 1000) is a mitochondrial complex i (nadh dehydrogenase) inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for metformin?
APO-METFORMIN XR 1000 is a marketed brand name for metformin. Check FDA Drugs@FDA for the current US label holder and prescribing information.